Lakeside subsidiary to acquire 100% of Hupan Pharmaceutical for RMB4M (US$0.6M)

Lakeside Holding Ltd

Lakeside's subsidiary Sichuan Hupan signs deal to acquire 100% of Hupan Pharmaceutical for RMB4.0M (US$0.6M).
Payment in three installments: 20% prepayment (RMB800K) within 7 days post-signing, 60% after conditions, 20% on completion.
Sellers Hubei Haoyaoshi (90%) and Hubei Huayao (10%) transfer all equity; no third-party interests.
Target provides pharmaceutical distribution, supply chain, brand promotion, and healthcare technology support.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.